Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
The present invention relates to a reconstitutable composition comprising at least one alginate, an aqueous diet preparation comprising said composition and the use of the aqueous diet preparation for the treatment and/or prevention of overweight for both therapeutic and non-therapeutic
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF INVENTION
The invention relates to a method for treating overweight individuals or patients with obesity using a food composition able to control the release of glucose into the patient's blood. This is achieved by the introduction into the food composition of a hydrophilic food grade
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to an agent for preventing or ameliorating obesity, to an agent for inhibiting accumulation of visceral fat, to an agent for inhibiting accumulation of liver lipid, and to an agent for preventing or ameliorating fatty liver.
BACKGROUND OF THE
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to a method for the treatment and/or prevention of overweight, said method comprising administering to a monogastric mammal a pectin and/or alginate containing liquid composition.
STATE OF THE ART
In effect, overweight in mammals is caused by the
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to a composition, which is liquid at around neutral pH and forms a viscous matrix at low pH, the composition comprising pectin, calcium and oligosaccharides. The present composition is particularly suitable for use in a method of treating or
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to a composition, which is liquid at around neutral pH and forms a viscous matrix at low pH, the composition comprising pectin, calcium and oligosaccharides. The present composition is particularly suitable for use in a method of treating or
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to low molecular weight polymannuronate, and more particularly, the present invention relates to an isolated low molecular weight polymannuronate composition, and a process for preparing thereof from high molecular
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present disclosure relates to non-reducing end unsaturated mannuronic acid oligosaccharides and compositions containing the same as an active ingredient.
BACKGROUND
In the modern world, the functional food market is expanding with the increase in complex metabolic syndromes caused by
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit and priority of Korean Patent Application No. 10-2015-0043404, filed 27 Mar. 2015. The entire disclosure of the above applications is incorporated herein by references.
FIELD
The present disclosure relates to non-reducing
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot. * All information baseras på publicerad vetenskaplig forskning